BCL6 (B-cell lymphoma 6) expression in adenomyosis, leiomyomas and normal myometrium.
Ontology highlight
ABSTRACT: Adenomyosis and leiomyomas are common benign uterine disorders characterized by abnormal cellular proliferation. The BCL6 protein, a transcriptional repressor implicated in cell proliferation and oncogenesis, has been linked to the pathogenesis of endometriosis. This study investigates BCL6 expression in adenomyosis, leiomyomas, and normal myometrium using immunohistochemistry and deep learning neural networks. We analyzed paraffin blocks from total hysterectomies performed between 2009 and 2017, confirming diagnoses through pathological review. Immunohistochemistry was conducted using an automated system, and BCL6 expression was quantified using Fiji-ImageJ software. A supervised deep learning neural network was employed to classify samples based on DAB staining. Our results show that BCL
SUBMITTER: Salas LC
PROVIDER: S-EPMC11793761 | biostudies-literature | 2025
REPOSITORIES: biostudies-literature
ACCESS DATA